» Articles » PMID: 30002273

Evaluation of a Tool to Measure Pharmacists' Readiness to Manage Intimate Partner Violence

Overview
Date 2018 Jul 14
PMID 30002273
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Intimate partner violence (IPV) is a public health problem that demands a comprehensive health care response. Provider education and training is needed for the entire health care team, including pharmacists, to competently care for IPV-impacted patients. Standardized assessments are needed to determine need for training and to evaluate the effectiveness of IPV training initiatives. The Physician Readiness to Manage Intimate Partner Violence Survey (PREMIS) has previously been validated for physicians. This study adapted and evaluated the PREMIS instrument for use with pharmacists to assess knowledge, attitudes, behaviors, and intentions related to IPV and IPV screening. A total of 144 surveys from community pharmacists were analyzed. Pharmacists had low levels of IPV knowledge. Exploratory factor analysis revealed a five-factor structure: workplace and self-efficacy, preparation, legal requirements, alcohol and drugs, and constraints. This instrument can be utilized to guide the development and implementation of IPV-related training initiatives for pharmacists.

Citing Articles

Intimate partner violence and women living with episodic disabilities: a scoping review protocol.

Campbell K, Ford-Gilboe M, Stanley M, MacKinnon K Syst Rev. 2022; 11(1):97.

PMID: 35585642 PMC: 9115998. DOI: 10.1186/s13643-022-01972-x.


Measuring the readiness to screen and manage intimate partner violence: Cross-cultural adaptation and psychometric evaluation of the PREMIS tool for perinatal care providers.

Guiguet-Auclair C, Debost-Legrand A, Lemery D, Barasinski C, Mulin B, Vendittelli F PLoS One. 2021; 16(11):e0258943.

PMID: 34735470 PMC: 8568123. DOI: 10.1371/journal.pone.0258943.


Improving Readiness to Manage Intimate Partner Violence in Family Medicine Clinics by Collaboration With a Community Organization.

Martin-Engel L, Allen J, Alencar A, Levin S, Udezi V, Pagels P PRiMER. 2021; 5:20.

PMID: 34286223 PMC: 8284494. DOI: 10.22454/PRiMER.2021.717020.


Knowledge, attitude, and preparedness toward IPV care provision among nurses and midwives in Tanzania.

Ambikile J, Leshabari S, Ohnishi M Hum Resour Health. 2020; 18(1):56.

PMID: 32746849 PMC: 7398074. DOI: 10.1186/s12960-020-00499-3.


Preparing Pharmacists to Care for Patients Exposed to Intimate Partner Violence.

Barnard M, White A, Bouldin A Pharmacy (Basel). 2020; 8(2).

PMID: 32531936 PMC: 7357068. DOI: 10.3390/pharmacy8020100.


References
1.
Coker A, Davis K, Arias I, Desai S, Sanderson M, Brandt H . Physical and mental health effects of intimate partner violence for men and women. Am J Prev Med. 2002; 23(4):260-8. DOI: 10.1016/s0749-3797(02)00514-7. View

2.
Hilverding A, DiPietro Mager N . Pharmacists' attitudes regarding provision of sexual and reproductive health services. J Am Pharm Assoc (2003). 2017; 57(4):493-497. DOI: 10.1016/j.japh.2017.04.464. View

3.
Plichta S . Intimate partner violence and physical health consequences: policy and practice implications. J Interpers Violence. 2004; 19(11):1296-323. DOI: 10.1177/0886260504269685. View

4.
Papadakaki M, Prokopiadou D, Petridou E, Kogevinas M, Lionis C . Defining physicians' readiness to screen and manage intimate partner violence in Greek primary care settings. Eval Health Prof. 2011; 35(2):199-220. DOI: 10.1177/0163278711423937. View

5.
Dent L, Harris K, Noonan C . Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009; 43(2):194-201. DOI: 10.1345/aph.1L556. View